Rare diseases
Investigational molecules
Locations
Back to Italy2 209 clinical trials in Rome, Italy across 15 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Phase I/II Study of AZD6621 Safety and Efficacy in Adult Men with Metastatic Prostate Cancer
ItalyEffectiveness and Safety of Pegcetacoplan in Patients with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative Glomerulonephritis
ItalyA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
ItalyStudy of MK-1045 versus blinatumomab with tocilizumab in patients with relapsed or refractory B-cell acute lymphoblastic leukemia
ItalyStudy of MK-1084 plus durvalumab versus placebo plus durvalumab in patients with locally advanced KRAS G12C‑mutant non‑small cell lung cancer after chemoradiotherapy
ItalyStudy of ly4395089 and mirikizumab in adults with moderately to severely active Crohn’s disease
ItalyVenetoclax added to fludarabine, cytarabine and gemtuzumab ozogamicin (drug combination) in children with relapsed acute myeloid leukemia
ItalyStudy of MK-1045 plus rituximab in patients with newly diagnosed follicular lymphoma
ItalySafety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
ItalyStudy of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients
ItalyA Phase 2/3 Study of intravitreal mk-8748 versus aflibercept in adults with neovascular age‑related macular degeneration
ItalyEvaluation of NXT007 versus Emicizumab Prophylaxis in Patients with Hemophilia A
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical studies focusing on Idiopathic Pulmonary Fibrosis and COPD, evaluating new therapeutic approaches for improving lung function and reducing disease progression.
Advanced research includes novel antibody treatments and preventive measures for respiratory infections.
Innovative trials targeting metastatic colorectal cancer, gastric cancer, and acute myeloid leukemia, exploring new treatment combinations and targeted therapies.
Studies focus on improving response rates and survival outcomes in various cancer types.
Research into Parkinson's disease and acute ischemic stroke, investigating novel therapeutic approaches and neuroprotective strategies.
Studies aim to improve neurological outcomes and patient quality of life.
Clinical trials examining Immune Thrombocytopenia and Hidradenitis Suppurativa, testing new therapeutic agents for immune-mediated conditions.
Research focuses on improving treatment outcomes in challenging immune disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
